ALDH2 and metabolic dysfunction-associated steatotic liver disease: Additionally, DEA (1) also exhibited protective effects against non-alcoholic fatty liver disease (NAFLD) through activating ALDH2 and accelerating the elimination of ROS and harmful aldehydes [40].